She was 6 days without antipsychotic drugs, she took only lorazepam 10-15mg daily, subsequently she developed a relapse of psychotic symptoms with strong suicidal ideation and multiple acts of selfharming. White blood cell count started to rise to 2300/mm3 within those 6 days. Than she was ...
Referring to a few other case reports of early relapse after an initial response to atypical antipsychotics other than olanzapine, the possibility is discussed that rapid displacement of these drugs due to loose binding could play a role in early relapse.A. E. Kostakoǧlu...
Maintenance Treatment — The effectiveness of oral olanzapine, 10 mg/day to 20 mg/day, in maintaining treatment response in schizophrenic patients who had been stable on olanzapine orally disintegrating tablets for approximately 8 weeks and were then followed for relapse has been demonstrated in a pl...
Double-Blind Comparison of Olanzapine Versus Risperidone in the Treatment of Schizophrenia and Other Psychotic Disorders. [Article] OBJECTIVE: The safety and efficacy of risperidone and olanzapine were compared in a double-blind trial that used doses widely accepted in clinical practice... P Tran,S...
Olanzapine is an atypical antipsychotic currently with indications for the treatment of schizophrenia, acute mania and the prevention of relapse in bipolar... B Fulton,KL Goa 被引量: 3发表: 2012年 Paliperidone extended release: a review of its use in the management of schizophrenia. Chwieduk CM...
We examined the relationship among olanzapine exposure, relapse, and changes in brain structure in patients with major depressive disorder with psychotic features. We analyzed data from the Study of the Pharmacotherapy of Psychotic Depression II trial (STOP-PD II), a randomized, placebo-controlled ...
The olanzapine and fluoxetine capsule-controlled column includes patients with various diagnoses while the placebo column includes only patients with bipolar depression and major depression with psychotic features. Table 16: Adverse Reactions: Incidence in the Short-Term Controlled Clinical Studies in Adults...
P.3.c.003 Olanzapine versus ziprasidone in parenteral administration in psychotic relapse of schizophreniadoi:10.1016/S0924-977X(06)70490-4C. TudorD. UngureanuM. D. GheorgheElsevier B.V.European Neuropsychopharmacology
The exact place of olanzapine in the therapy of psychotic patients remains unclear, as more data are needed to evaluate the long-term efficacy of this agent, its impact on negative symptoms, and its potential use in patients resistant to the standard agents. Despite limitations in the current ...
The drug product is olanzapine pamoate monohydrate, present as a yellow solid in a glass vial equivalent to 210, 300, or 405 mg olanzapine base per vial. The diluent for ZYPREXA RELPREVV is a clear, colorless to slightly yellow solution in a glass vial and is composed of carboxymethylcellulos...